New York State Common Retirement Fund
CAPR icon

New York State Common Retirement Fund’s Capricor Therapeutics CAPR Stock Holding History

New York State Common Retirement Fund’s Portfolio CAPR Stock Details CAPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$455K Buy
18,900
+5,900
+45% +$179K ﹤0.01% 2043
2026
Q1 		$395K Hold
13,000
– – ﹤0.01% 1995
2025
Q4 		$375K Buy
13,000
+7,200
+124% +$94K ﹤0.01% 2066
2025
Q3 		$41.8K Hold
5,800
– – ﹤0.01% 2996
2025
Q2 		$57.6K Hold
5,800
– – ﹤0.01% 2904
2025
Q1 		$55K Hold
5,800
– – ﹤0.01% 2741
2024
Q4 		$80K Buy
5,800
+5,000
+625% +$87.6K ﹤0.01% 2685
2024
Q3 		$12.2K Sell
800
-20,800
-96% -$103K ﹤0.01% 3094
2024
Q2 		$103K Buy
+21,600
New +$120K ﹤0.01% 2777

Other funds holding CAPR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

New York State Common Retirement Fund's CAPR Position: Q2 2026 in Review

New York State Common Retirement Fund increased its Capricor Therapeutics (CAPR) stake by 45% in Q2 2026, buying an estimated $179K and bringing the position to 18,900 shares worth $455K. The position accounts for ﹤0.01% of the portfolio, ranked #2043.

New York State Common Retirement Fund first reported a position in CAPR in Q2 2024 and has held it in 9 quarters since. 169 funds tracked by Wall St. Rank hold CAPR as of Q2 2026.

  • New York State Common Retirement Fund held 18,900 shares of Capricor Therapeutics worth $455K as of Q2 2026.
  • New York State Common Retirement Fund bought 5,900 Capricor Therapeutics shares in Q2 2026, an estimated $179K.
  • Capricor Therapeutics made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #2043 holding.
  • New York State Common Retirement Fund first reported a position in Capricor Therapeutics in Q2 2024 and has held it in 9 quarters since.
  • 169 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.